未登录

P

Pawinee Rerknimitr

chulalongkorn university

H指数:22

被引数:1,794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study

寻常天疱疮的发病率趋势及住院严重不良结局：一项全国性队列研究

The Journal of Dermatology

IF0

2026-05-290

PRE

A Global Delphi Consensus on Acne and the Microbiome: Integrating International Expertise for Innovative Prevention and Therapeutic Strategies

全球德尔菲共识：痤疮与微生物组——整合国际专家智慧，创新预防与治疗策略

Pharmaceuticals

IF4.8

2026-04-290

OAAI

Nail Fold Microbiome Alterations in Patients Treated With Epidermal Growth Factor Receptor Inhibitors

接受表皮生长因子受体抑制剂治疗患者的甲皱微生物组改变

Experimental Dermatology

IF3.1

2026-01-080

PRE

A 10-year retrospective crosssectional study of severe cutaneous adverse drug reactions in Thailand: Human leukocyte antigen typing and enzyme-linked immunospot assay-assisted drug identification

一项关于泰国严重皮肤不良反应的10年回顾性横断面研究：人类白细胞抗原分型与酶联免疫斑点试验辅助药物识别

JAAD International

IF5.2

2025-11-010

OAAI

Wongtada, Chanidapa; Charoenchaipiyakul, Kridipop; Chariyavilaskul, Pajaree; Chongpison, Yuda; Buranapraditkun, Supranee; Thantiworasit, Pattarawat; Mongkolpathumrat, Pungjai; Chularojanamontri, Leena; Tuchinda, Papapit; Srinoulprasert, Yuttana; Rerkpattanapipat, Ticha; Chanprapaph, Kumutnart; Disphanurat, Wareeporn; Chakkavittumrong, Panlop; Pongcharoen, Padcha; Tovanabutra, Napatra; Srisuttiyakorn, Chutika; Sukasem, Chonlaphat; Pinyopornpanish, Kanokkarn; Rerknimitr, Pawinee; Klaewsongkram, Jettanong

Bullous dermatologic reactions in immune checkpoint inhibitor therapy: A systematic review

免疫检查点抑制剂治疗中的大疱性皮肤反应：系统综述

JAAD International

IF5.2

2025-11-010

OAAI

Dysregulation of Regulatory T Cells and Autoimmune Sequelae in DRESS: Insights From Flow Cytometry and NanoString Analysis

EXPERIMENTAL DERMATOLOGY

IF3.1

2024-11-020

OA

Combining dipyridamole and cilostazol with up-dosing antihistamines improves outcomes in chronic spontaneous urticaria with high D-dimer levels: A randomized controlled trial

EXPERIMENTAL DERMATOLOGY

IF3.1

2024-08-221

PRE

Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non-beta lactam antibiotics

整合体内和离体方法以鉴定非 β-内酰胺类抗生素引起的皮肤不良药物反应中的罪犯药物

EXPERIMENTAL DERMATOLOGY

IF3.1

2024-04-230

PRE

IFN-γ ELISpot-enabled machine learning for culprit drug identification in nonimmediate drug hypersensitivity

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IF11.2

2024-01-015

PRE

Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)

SCIENTIFIC REPORTS

IF3.9

2023-08-217

OAAI

Key factors predicting the in-hospital mortality of patients with severe cutaneous adverse reactions in Thailand

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2023-05-275

PRE

Exosomal microRNAs from PBMCs stimulated with culprit drugs enhanced keratinocyte cell death in Stevens-Johnson syndrome/toxic epidermal necrolysis

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2023-03-231

OA

Skin testing might have a diagnostic role in immune complex-mediated hypersensitivity reactions

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2022-10-200

PRE

Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis

新型冠状病毒肺炎疫苗接种后皮肤不良反应的全球患病率和临床表现: 系统评价和荟萃分析

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2022-06-2123

OA

Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindication for revaccination

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2022-04-019

OA

Cutaneous adverse reactions from 35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort study in healthcare workers

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IF8

2021-10-2918

OA

Clinical parameters and biological markers associated with acute severe ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis

SCIENTIFIC REPORTS

IF3.9

2021-10-128

OAAI

Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination

CLINICAL AND EXPERIMENTAL DERMATOLOGY

IF2.8

2021-10-1011

OA

Glutathione Whitening Pills Induced Toxic Epidermal Necrolysis: An Unusual Case Confirmed by Enzyme-Linked Immunospot Assay and Liquid Chromatography-Mass Spectrometry

IF3.2

2021-10-012

PRE

Role of antimicrobial peptides in atopic dermatitis

INTERNATIONAL JOURNAL OF DERMATOLOGY

IF3.2

2021-08-2518

PREAI